Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGN-229666 for the Treatment of Allergic Conjunctivitis

NCT01754766 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01754766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01754766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGN-229666 for the Treatment of Allergic Conjunctivitis
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2012
Completion date
February 28, 2013
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis